Movatterモバイル変換


[0]ホーム

URL:


Drug Approval Package
Quick Links: Skip to main page contentSkip to SearchSkip to Topics MenuSkip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services
FDA, U.S. Food and Drug Administration
U.S. Food & Drug Administration
 
 

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Maxalt/Rizatritan Benzoate
Company:  Merck
Application No.:  20864 & 20865
Approval Date: 6/29/1998

 

Date created: March 30, 2001; last update: July 5, 2005

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require theAdobe Acrobat Reader®.

-
-

Links on this page:


FDA
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
Ph. 1-888-INFO-FDA (1-888-463-6332)
Contact FDA
  • USA.gov
  • E-mail
  • RSS
  • Twitter
  • Facebook
  • YouTube
  • Flickr
U.S. Department of Health & Human Services
 

Links on this page:


[8]ページ先頭

©2009-2025 Movatter.jp